National Bank of Canada
XERS icon

National Bank of Canada’s Xeris Biopharma Holdings XERS Stock Holding History

National Bank of Canada’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,890
Closed -$4.1K – 3072
2024
Q2 		$4.1K Sell
1,890
-495
-21% -$998 ﹤0.01% 2306
2024
Q1 		$4.2K Hold
2,385
– – ﹤0.01% 2344
2023
Q4 		$5.39K Hold
2,385
– – ﹤0.01% 2291
2023
Q3 		$4.17K Hold
2,385
– – ﹤0.01% 2384
2023
Q2 		$6.22K Hold
2,385
– – ﹤0.01% 2293
2023
Q1 		$3.86K Buy
+2,385
New +$2.99K ﹤0.01% 2339

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

National Bank of Canada's XERS Position: Q3 2024 in Review

National Bank of Canada sold out of Xeris Biopharma Holdings (XERS) in Q3 2024, closing a stake of 1,890 shares — an estimated $4.1K sold.

National Bank of Canada first reported a position in XERS in Q1 2023 and held it in 6 quarters. The position peaked at $6.22K in Q2 2023. 144 funds tracked by Wall St. Rank hold XERS as of Q3 2024.

  • National Bank of Canada reported no remaining Xeris Biopharma Holdings position as of Q3 2024 after selling out during the quarter.
  • National Bank of Canada sold 1,890 Xeris Biopharma Holdings shares in Q3 2024, an estimated $4.1K.
  • National Bank of Canada first reported a position in Xeris Biopharma Holdings in Q1 2023 and held it in 6 quarters.
  • National Bank of Canada's Xeris Biopharma Holdings position peaked at $6.22K in Q2 2023.
  • 144 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2024.

Based on National Bank of Canada's 13F filing for Q3 2024, filed 12 Nov 2024.